Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3215]

AACR 2015: Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma

AACR 2015: Pembrolizumab safe, with signs of clinical benefit, for patients with malignant pleural mesothelioma

AACR 2015: New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

AACR 2015: New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

AACR 2015: Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

AACR 2015: Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

Active Pin1 is a target for all-trans retinoic acid in leukaemia and breast cancer

Active Pin1 is a target for all-trans retinoic acid in leukaemia and breast cancer

New assay helps determine lymphoma subtypes simply, quickly, and inexpensively

New assay helps determine lymphoma subtypes simply, quickly, and inexpensively

Methylcytosine dioxygenase TET1 is a haematopoietic tumour repressor

Methylcytosine dioxygenase TET1 is a haematopoietic tumour repressor

Current and future challenges of innovative oncology drug development

Current and future challenges of innovative oncology drug development

Scientists trace genomic evolution of high-risk leukaemia

Scientists trace genomic evolution of high-risk leukaemia

Researchers effectively and safely overcome radiation resistance in leukaemia with an engineered precision medicine

Researchers effectively and safely overcome radiation resistance in leukaemia with an engineered precision medicine

New treatment for mantle cell lymphoma available for patients in the UK

New treatment for mantle cell lymphoma available for patients in the UK

More from ecancer